Today's Trend
Gentex Corporation (NASDAQ: GNTX) shares have increased as investors weigh a generally improved near- and medium-term earnings outlook from Zacks Research. The analyst firm raised its FY2026 EPS forecast to $1.99 from $1.91 and its FY2027 estimate to $2.15 from $2.13, while also increasing estimates for Q3 and Q4 2026, Q3 2027 and Q4 2027.
- Zacks raised its Q3 2026 EPS estimate to $0.51 from $0.49 and lifted its Q4 2026 forecast to $0.48 from $0.47, suggesting improved expectations for Gentex’s near-term profitability.
- The firm increased its FY2026 EPS outlook to $1.99 and FY2027 forecast to $2.15. It also raised Q3 2027 EPS to $0.60 from $0.55 and Q4 2027 EPS to $0.53 from $0.49.
- Gentex’s projected FY2026 earnings are now closer to the broader consensus estimate of $2.02 per share, which may support the stock’s modest advance.
- The analyst maintained estimates of $2.56 EPS for FY2028, indicating expectations for continued earnings growth, although the forecast remains below the previous $2.60 estimate.
- Zacks reduced EPS estimates for Q1 2027 to $0.48 from $0.51, Q2 2027 to $0.54 from $0.57, and Q1 2028 to $0.57 from $0.62. These cuts point to some softness in portions of the projected earnings path.
Overall, the revisions are mixed but skew positive for the periods closest to the current forecast horizon. Gentex’s prior quarterly results also showed earnings above analyst expectations, though revenue declined slightly year over year, leaving investors focused on whether the improved profit outlook can be sustained.